file1
,
file2
, etc. all in the same folder or directory;
first, locate one of the files with the [Browse...] button. Then alter the
file path in the box above to include '*' character (eg. file*
).
Wildcard '?' to blanket only one character works too.Historiographs |
Grand Totals: LCS 17722, GCS 106366, CR 136943 Collection span: 1963 - 2012 | |
Word(i) List (4568) Word count: 24159, All words count: 34321 |
# | Word | Recs | TLCS | TGCS |
---|---|---|---|---|
801 | PROTEINS | 7 | 9 | 157 |
802 | RELATION | 8 | 25 | 157 |
803 | SIBLING | 2 | 11 | 157 |
804 | SUPPRESSANT | 1 | 11 | 157 |
805 | TECHNOLOGY | 2 | 13 | 157 |
806 | DOCUMENT | 1 | 13 | 156 |
807 | HEMIKETALS | 1 | 13 | 156 |
808 | TESTING | 6 | 42 | 156 |
809 | TRICARBONYL | 1 | 13 | 156 |
810 | PROGNOSIS | 6 | 41 | 155 |
811 | VENOUS | 11 | 17 | 155 |
812 | HOMOTRANSPLANTS | 5 | 24 | 154 |
813 | INTERINDIVIDUAL | 1 | 4 | 154 |
814 | MINIMAL | 5 | 25 | 154 |
815 | OVERVIEW | 5 | 3 | 154 |
816 | P450 | 1 | 4 | 154 |
817 | GLUCOSE | 4 | 16 | 153 |
818 | KILLER | 7 | 20 | 153 |
819 | OKT3 | 6 | 24 | 153 |
820 | SHORT-TERM | 7 | 46 | 153 |
821 | 1ST | 3 | 15 | 152 |
822 | AMINO-ACID-SEQUENCE | 1 | 2 | 152 |
823 | ANTIINFLAMMATORY | 3 | 17 | 152 |
824 | BINDING-PROTEIN | 1 | 2 | 152 |
825 | CALF | 1 | 2 | 152 |
826 | DETERMINATION | 4 | 8 | 152 |
827 | HOMOTRANSPLANT | 2 | 19 | 152 |
828 | NON-TRANSPLANT-ASSOCIATED | 1 | 3 | 152 |
829 | CD40-CD40 | 1 | 15 | 151 |
830 | CHALLENGES | 8 | 18 | 151 |
# | Word | Recs | TLCS | TGCS |
831 | MITIGATES | 1 | 22 | 151 |
832 | RETRANSPLANTATION | 5 | 15 | 151 |
833 | ANTI-CD4 | 2 | 49 | 150 |
834 | CLINIC | 8 | 21 | 150 |
835 | HEMATOLYMPHOID | 3 | 98 | 150 |
836 | POSTOPERATIVE | 7 | 33 | 150 |
837 | STATES | 3 | 17 | 150 |
838 | EXCLUSIVELY | 1 | 11 | 149 |
839 | LEFLUNOMIDE | 3 | 6 | 149 |
840 | LEVEL | 6 | 13 | 149 |
841 | TUBULAR | 5 | 16 | 149 |
842 | ALTERS | 3 | 35 | 148 |
843 | FIRST | 6 | 13 | 148 |
844 | BINDING | 3 | 6 | 147 |
845 | EXPERIMENTS | 2 | 34 | 147 |
846 | MONOCLONAL | 8 | 7 | 147 |
847 | NEUROPROTECTION | 3 | 11 | 147 |
848 | PEDIATRIC-PATIENTS | 4 | 21 | 147 |
849 | SUPPRESSED | 2 | 26 | 147 |
850 | SWITCHING | 3 | 6 | 147 |
851 | EXPOSURE | 3 | 8 | 146 |
852 | MAST-CELLS | 2 | 17 | 146 |
853 | OPERATIONAL | 5 | 18 | 146 |
854 | HYPERLIPIDEMIA | 2 | 6 | 145 |
855 | RENAL-TRANSPLANTS | 8 | 22 | 145 |
856 | SUBPOPULATIONS | 6 | 14 | 145 |
857 | DESTRUCTION | 4 | 2 | 144 |
858 | HERPES-VIRUS-4 | 1 | 0 | 144 |
859 | HOMOLOG | 1 | 0 | 144 |
860 | OBSERVATION | 1 | 25 | 144 |
# | Word | Recs | TLCS | TGCS |
861 | SEVERITY | 2 | 12 | 144 |
862 | TEST | 3 | 34 | 144 |
863 | ANTIBODIES | 17 | 23 | 142 |
864 | FACTOR-STIMULATED | 1 | 42 | 142 |
865 | METHYLPREDNISOLONE | 5 | 14 | 142 |
866 | NEPHRECTOMY | 7 | 8 | 142 |
867 | PROTECTION | 5 | 8 | 142 |
868 | HEART-TRANSPLANTATION | 5 | 99 | 141 |
869 | NONHUMAN | 9 | 10 | 141 |
870 | POSTTRANSPLANTATION | 6 | 14 | 141 |
871 | CONTRIBUTE | 3 | 26 | 140 |
872 | GVH | 3 | 94 | 139 |
873 | INFANTS | 3 | 9 | 139 |
874 | PROTECTIVE | 5 | 9 | 139 |
875 | TRANSCRIPTION | 2 | 15 | 139 |
876 | ACHIEVING | 4 | 12 | 138 |
877 | IMMUNOFERRITIN | 1 | 15 | 138 |
878 | KEY | 1 | 31 | 138 |
879 | LINKED | 1 | 50 | 138 |
880 | PREDNISOLONE | 9 | 22 | 138 |
881 | SODIUM | 5 | 19 | 138 |
882 | SPLIT | 6 | 32 | 138 |
883 | ANALYTICAL | 4 | 22 | 137 |
884 | ANTIPROLIFERATIVE | 2 | 18 | 137 |
885 | BEINGS | 2 | 26 | 137 |
886 | DETERMINANT | 3 | 4 | 137 |
887 | HYBRIDIZATION | 3 | 24 | 137 |
888 | MEDIATED | 6 | 17 | 137 |
889 | SUPPRESSOR | 5 | 9 | 137 |
890 | 3-WEEK | 1 | 13 | 136 |
# | Word | Recs | TLCS | TGCS |
891 | ASSOCIATION | 8 | 32 | 136 |
892 | CEREBRAL | 6 | 9 | 136 |
893 | CONTROLLED | 6 | 34 | 136 |
894 | PATHOLOGICAL-CHANGES | 1 | 13 | 136 |
895 | PROGRAM | 2 | 10 | 136 |
896 | TUMOR | 10 | 13 | 136 |
897 | CYCLOSPORINE-ASSOCIATED | 2 | 9 | 135 |
898 | FOLDING | 2 | 1 | 135 |
899 | INBRED | 6 | 21 | 135 |
900 | ARTHRITIS | 5 | 8 | 134 |
901 | ATGAM | 2 | 15 | 134 |
902 | BIOPSY | 3 | 7 | 134 |
903 | CHEMICAL | 6 | 14 | 134 |
904 | CYA | 6 | 22 | 134 |
905 | DYSFUNCTION | 6 | 18 | 134 |
906 | GENDER | 4 | 1 | 134 |
907 | PLAQUE | 2 | 11 | 134 |
908 | RATIO | 2 | 26 | 134 |
909 | T-CELLS | 8 | 8 | 134 |
910 | BETA-CELL | 2 | 7 | 133 |
911 | EPSTEIN-BARR | 4 | 5 | 133 |
912 | MULTIVISCERAL | 11 | 19 | 133 |
913 | PHENYTOIN | 1 | 7 | 133 |
914 | STATE | 6 | 45 | 133 |
915 | ADVERSE | 5 | 17 | 132 |
916 | HIGH-RISK | 5 | 19 | 132 |
917 | METHOD | 9 | 8 | 132 |
918 | PILOT | 2 | 16 | 132 |
919 | PRACTICAL | 6 | 26 | 132 |
920 | PROMOTES | 4 | 11 | 132 |
# | Word | Recs | TLCS | TGCS |
921 | STRUCTURAL | 4 | 18 | 132 |
922 | DEMONSTRATE | 1 | 13 | 131 |
923 | DRAINAGE | 9 | 21 | 131 |
924 | ESTABLISHED | 9 | 63 | 131 |
925 | EXOCYTOSIS | 1 | 13 | 131 |
926 | METABOLIC | 6 | 14 | 130 |
927 | METHODS | 8 | 22 | 130 |
928 | TIMING | 5 | 15 | 130 |
929 | TRAFFICKING | 2 | 95 | 130 |
930 | DEFINING | 1 | 50 | 129 |
931 | PRIMATE | 7 | 17 | 129 |
932 | WORLD | 3 | 13 | 129 |
933 | POWERFUL | 2 | 9 | 128 |
934 | BONE-MARROW-DERIVED | 2 | 27 | 127 |
935 | DETERRENTS | 1 | 24 | 127 |
936 | PAIRED | 1 | 7 | 127 |
937 | CHOLESTATIC | 2 | 5 | 126 |
938 | MELANOMA | 5 | 0 | 126 |
939 | MULTIDRUG | 2 | 0 | 126 |
940 | NEGATIVE | 3 | 9 | 126 |
941 | ENDOTHELIUM | 5 | 10 | 125 |
942 | FRONTIER | 3 | 14 | 125 |
943 | INJECTION | 18 | 21 | 125 |
944 | INTERLEUKIN-1 | 1 | 1 | 125 |
945 | LYMPHOCYTE-B | 2 | 7 | 125 |
946 | LYMPHOCYTE-T | 2 | 7 | 125 |
947 | SAMPLE | 3 | 11 | 125 |
948 | STIMULANTS | 1 | 1 | 125 |
949 | AUGMENTS | 5 | 34 | 124 |
950 | CAMPATH | 2 | 23 | 124 |
# | Word | Recs | TLCS | TGCS |
951 | CYCLOSPORIN-INDUCED | 7 | 13 | 124 |
952 | PRETRANSPLANT | 6 | 20 | 124 |
953 | CHAIN | 9 | 49 | 123 |
954 | DISSOCIATION | 4 | 14 | 123 |
955 | INTRAGRAFT | 7 | 32 | 123 |
956 | APPLICATIONS | 10 | 11 | 122 |
957 | COMPARATIVE-STUDY | 3 | 7 | 122 |
958 | STUDIED | 2 | 7 | 122 |
959 | BLOOD-PRESSURE | 3 | 3 | 121 |
960 | CYCLOSPORINE-BASED | 3 | 18 | 121 |
961 | PATHOLOGICAL | 2 | 4 | 121 |
962 | RAT-LIVER | 2 | 66 | 121 |
963 | UNRELATED | 4 | 1 | 121 |
964 | BENEFITS | 7 | 16 | 120 |
965 | COLD | 2 | 20 | 120 |
966 | PRODUCED | 7 | 22 | 120 |
967 | SINGLE-CELL | 1 | 7 | 120 |
968 | EXTENDED | 1 | 17 | 119 |
969 | INTRARENAL | 3 | 7 | 119 |
970 | DUCTOPENIC | 3 | 28 | 118 |
971 | INTERMEDIATE-TERM | 2 | 23 | 118 |
972 | NODE | 2 | 10 | 118 |
973 | PROTEIN-12 | 1 | 6 | 118 |
974 | REFRACTORY | 5 | 21 | 118 |
975 | TH1-AND | 1 | 11 | 118 |
976 | TH2-LIKE | 1 | 11 | 118 |
977 | ALLOGRAFTING | 5 | 7 | 117 |
978 | B-CELL | 2 | 12 | 117 |
979 | CORRELATIONS | 3 | 62 | 117 |
980 | DOSE-DEPENDENCE | 1 | 19 | 117 |
# | Word | Recs | TLCS | TGCS |
981 | IMMUNE-MEDIATED | 2 | 1 | 117 |
982 | LECTURE | 3 | 4 | 117 |
983 | LOWER | 3 | 29 | 117 |
984 | POPULATION | 7 | 16 | 117 |
985 | PREPARATIONS | 7 | 14 | 117 |
986 | RECENT | 5 | 2 | 117 |
987 | UNITED | 2 | 11 | 117 |
988 | ACTIVITIES | 5 | 15 | 116 |
989 | EXPERIENCES | 5 | 26 | 116 |
990 | LIGHT | 2 | 17 | 116 |
991 | ORGANS | 9 | 29 | 116 |
992 | TARGETING | 3 | 1 | 116 |
993 | ANIMAL-MODEL | 3 | 9 | 115 |
994 | CHAIN-REACTION | 7 | 59 | 115 |
995 | ENHANCES | 5 | 3 | 115 |
996 | HIGH-PERFORMANCE | 5 | 4 | 115 |
997 | PREGNANCY | 5 | 6 | 115 |
998 | SUSTAINED | 2 | 34 | 115 |
999 | DETECT | 5 | 16 | 114 |
1000 | DOSES | 7 | 12 | 114 |